EOVIST
Gadoxetate Disodium
Listed by Bayer HealthCare Pharmaceuticals Inc.
- Strength
- 181.43 mg/mL
- Form
- Injection, Solution
- Route
- Intravenous
- Class
- Gadolinium-based Contrast Agent
What it contains
- Gadoxetate Disodium 181.43 mg/mL
FDA record
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravenous |
| Drug class | Gadolinium-based Contrast Agent |
| Approval route | NDA — original brand approval |
| NDC code | 50419-320 |
| FDA application | NDA022090 |
| Package sizes listed | 3 |
| Marketed since | July 2008 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.